Advanced search
Publication Cover
Infection and Drug Resistance Volume 13, 2020 - Issue
Submit an article Journal homepage
142
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Application Value of Triton X-100 to Modified Hodge Test and Carbapenem Inactivation Method in the Detection of Acinetobacter baumannii Carbapenemase

Shijian Fan1 Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei City230022, People’s Republic of China
,
Yaqian Dai1 Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei City230022, People’s Republic of China
,
Lixia Hou1 Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei City230022, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-8359-6756
ORCID Icon &
Yuanhong Xu1 Department of Clinical Laboratory, The First Affiliated Hospital of Anhui Medical University, Hefei City230022, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-1637-3800
ORCID Icon
Pages 4283-4288 | Published online: 24 Nov 2020

References

  • Trebosc V, Gartenmann S, Tötzl M, et al. Dissecting colistin resistance mechanisms in extensively drug-resistant acinetobacter baumannii clinical isolates. mBio. 2019;10(4):e01083–19.31311879
  • Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582.18625687
  • Nowak P, Paluchowska P. Acinetobacter baumannii: biology and drug resistance - role of carbapenemases. Folia Histochem Cytobiol. 2016;54(2):61–74.27270503
  • CLSI. Performance Standards for Antimicrobial Disk Susceptibility Testing, Twenty-Fifth Informational Supplement. CLSI Document M100-S25. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.
  • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 28th ed. CLSI Supplement M100-S28[S]. Wayne PA: CLSI; 2018:112–122.
  • Simner PJ, Johnson JK, Brasso WB, et al. Multicenter evaluation of the modified carbapenem inactivation method and the carba NP for detection of carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii. J Clin Microbiol. 2017;56(1):e01369–17. doi:10.1128/JCM.01369-1729118172
  • Simner PJ, Opene BNA, Chambers KK, Naumann ME, Carroll KC, Tamma PD. Carbapenemase detection among carbapenem-resistant glucose-nonfermenting gram-negative Bacilli. J Clin Microbiol. 2017;55(9):2858–2864. doi:10.1128/JCM.00775-1728701421
  • Pasteran F, Gonzalez LJ, Albornoz E, Bahr G, Vila AJ, Corso A. Triton Hodge test: improved protocol for modified Hodge test for enhanced detection of NDM and other carbapenemase producers. J Clin Microbiol. 2016;54(3):640–649. doi:10.1128/JCM.01298-1526719442
  • Liu M, Song Q, Wu L, et al. Triton X-100 and increased volume of test bacteria in the carbapenem inactivation method enhanced the detection of carbapenemase-producing Acinetobacter baumannii complex isolates. J Clin Microbiol. 2018;56(3):e01982–17. doi:10.1128/JCM.01982-1729305537
  • van der Zwaluw K, de Haan A, Pluister GN, Bootsma HJ, de Neeling AJ, Schouls LM. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PLoS One. 2015;10(3):e0123690. doi:10.1371/journal.pone.012369025798828
  • Pierce VM, Simner PJ, Lonsway DR, et al. Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among enterobacteriaceae. J Clin Microbiol. 2017;55(8):2321–2333. doi:10.1128/JCM.00193-1728381609
  • Smith CA, Antunes NT, Stewart NK, et al. Structural basis for enhancement of carbapenemase activity in the OXA-51 family of class D β-lactamases. ACS Chem Biol. 2015;10(8):1791–1796. doi:10.1021/acschembio.5b0009026042471
  • Chen TL, Lee YT, Kuo SC, et al. Emergence and distribution of plasmids bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. Antimicrob Agents Chemother. 2010;54(11):4575–4581. doi:10.1128/AAC.00764-1020713680
  • He C, Xie Y, Zhang L, et al. Increasing imipenem resistance and dissemination of the ISAba1-associated blaOXA-23 gene among Acinetobacter baumannii isolates in an intensive care unit. J Med Microbiol. 2011;60(Pt 3):337–341. doi:10.1099/jmm.0.022681-021127157
  • Byun JH, Gim JL, Yum JH, Yong D, Lee K, Chong Y. Modification and evaluation of the Triton Hodge test for screening carbapenemase-producing Enterobacteriaceae. Diagn Microbiol Infect Dis. 2019;95(4):114872. doi:10.1016/j.diagmicrobio.2019.11487231466876
  • Sun K, Xu X, Yan J, Zhang L. Evaluation of six phenotypic methods for the detection of carbapenemases in gram-negative bacteria with characterized resistance mechanisms. Ann Lab Med. 2017;37(4):305–312. doi:10.3343/alm.2017.37.4.30528445009
  • Pasteran F, Tijet N, Melano RG, Corso A, Bourbeau P. Simplified protocol for carba NP test for enhanced detection of carbapenemase producers directly from bacterial cultures. J Clin Microbiol. 2015;53(12):3908–3911. doi:10.1128/JCM.02032-1526424841
  • Yan Q, Liu Q, Li Y, et al. Detection of carbapenemase-producing gram-negative bacteria using a simplified carba NP test. J Microbiol Methods. 2016;123:1–3. doi:10.1016/j.mimet.2016.02.00826854838
  • Yamada K, Aoki K, Nagasawa T, et al. Carbapenem inactivation method using bacterial lysate and MOPS (LCIM): a very sensitive method for detecting carbapenemase-producing Acinetobacter species. J Antimicrob Chemother. 2020;75(10):2812–2816. doi:10.1093/jac/dkaa23832585695

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.